(Q48642876)

13 February 2018

title

Tumor-related prognostic factors for remission of brain metastases after radiotherapy. (English)

1 reference

13 February 2018

adaptive radiation therapy

main subject

0 references

1 reference

C Nieder

1

1 reference

13 February 2018

W Berberich

series ordinal

2

1 reference

13 February 2018

K Schnabel

series ordinal

3

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

13 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

13 February 2018

volume

39

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

25-30

1 reference

13 February 2018

Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Dose, volume, and tumor-control predictions in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Fractionated stereotactic external beam radiotherapy in the management of brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Relation between local result and total dose of radiotherapy for brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

CT characteristics of patients with brain metastases treated in RTOG study 79-16.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900154-5

7 January 2021

10.1016/S0360-3016(97)00154-5

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018